688366 昊海生科
2025/12 -
人民幣(K¥)

变动
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入2,472,998-8.33%2,654,0392,130,2761,766,9941,332,427
减:营业总成本2,136,274-4.80%2,187,7431,864,4201,483,2111,140,866
    其中:营业成本738,762-9.09%782,849660,761492,922334,004
               财务费用(60,671)24.57%(62,217)(74,097)(84,854)(99,123)
               资产减值损失(198,518)515.78%(6,741)(54,239)687(3,970)
公允价值变动收益31,06219.86%2,296(7,784)24--
投资收益4,542353.20%1,1425,80862,17236,845
    其中:对联营企业和合营企业的投资收益10-99.03%4563,5052,193(131)
营业利润220,210-55.49%507,413234,586383,410259,010
利润总额239,245-48.68%508,261235,727382,650257,025
减:所得税费用30,924-65.60%95,99145,39535,36630,686
净利润208,321-44.63%412,269190,332347,284226,338
减:非控股权益(42,687)-3.43%(3,852)9,862(4,951)(3,732)
股东净利润251,009-40.30%416,121180,470352,235230,070

市场价值指针
每股收益 (元) *1.080-40.00%1.7501.0402.0001.300
每股派息 (元) *1.0000.00%1.0000.4000.7000.500
每股净资产 (元) *23.516-1.64%32.94931.67032.49630.985
审计意见 #标准无保留意见标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容